Back to search

University of Sheffield

The Clinical Utility of Bone Turnover Markers in Postmenopausal Women with Osteoporosis

Abstract

dc:description.abstract

Postmenopausal osteoporosis is characterised by increased bone turnover, a negative balance (where bone resorption exceeds bone formation), reduced BMD and increased fracture risk. Diagnosis is based on assessment of BMD measured by DXA. The development of specific and sensitive bone turnover markers such as PINP and CTX are widely used in clinical studies. The overall aim of this thesis was to investigate the clinical utility of BTMs in a population based study and in clinical trials of licenced antiresorptive treatments. Postmenopausal and premenopausal women were recruited and whole blood, serum and urine samples were collected. Several diseases and treatments were identified that influenced bone turnover markers in older women and these needed to be excluded for establishing healthy reference intervals. In postmenopausal osteoporosis the negative balance between bone resorption and formation may be associated with the low BMD, bone loss and increased vertebral and non-vertebral fracture risk. Antiresorptive treatments inhibit bone resorption in the short-term by having direct action on mature osteoclasts. There was also a later effect mediated by a reduction in the population of circulating osteoclast precursors. With bisphosphonate treatments bone balance is positive relative to healthy premenopausal women. The clinical utility of sclerostin remains unclear but it does appear to be related to bone resorption and bone formation and levels of which are reduced with raloxifene treatment. Bone turnover markers provide additional information to BMD assessments about bone remodelling. The combined assessment of bone turnover and bone balance may help identify patients at risk of bone loss and fracture. These findings can be used to investigate the mechanisms of actions of current and future treatments that are being developed in order to identify the most suitable for patients with postmenopausal osteoporosis.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Sheffield
Year dc:date.issued
2017

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Gossiel, Fatma
Advisor dc:contributor.advisor
  • Eastell, Richard

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Identifier
uk.bl.ethos.837133

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Gossiel, Fatma. The Clinical Utility of Bone Turnover Markers in Postmenopausal Women with Osteoporosis. doctoral thesis, University of Sheffield, 2017.